Espay wins Lancet Neurology 20th anniversary essay competition
April 18, 2022
Dr. Alberto Espay won the Lancet Neurology journal's 20th anniversary essay competition.
April 18, 2022
Dr. Alberto Espay won the Lancet Neurology journal's 20th anniversary essay competition.
July 19, 2022
The University of Cincinnati's Eva Mistry joined 55KRC's Simply Medicine program to discuss the BEST-II clinical trial examining the effects of varying blood pressure targets for patients recovering from a stroke.
July 20, 2022
Yahoo News featured the University of Cincinnati's Jennifer Molano in an article about ways to boost your immunity during the BA.5 surge of COVID-19 cases.
July 25, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was a guest on 55KRC's Simply Medicine program to discuss his research into sickle cell disease, stroke and cognitive impairment.
July 7, 2022
The University of Cincinnati's Pooja Khatri commented on a new Danish study about how statins affect risk of stroke for Neurology Today.
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
May 24, 2022
The University of Cincinnati's College of Medicine and College-Conservatory of Music collaborate on the innovative Dementia and the Arts course and intervention for community members with cognitive disorders and their family members.
January 3, 2023
The University of Cincinnati's Eva Mistry is leading a new study with funding support from the Patient-Centered Outcomes Research Institute that will examine the effectiveness of a stroke treatment for patients with a pre-stroke disability, one of the first studies to focus on this population.
January 24, 2023
MedPage Today highlighted comments from a recent editorial written by the University of Cincinnati's Eva Mistry analyzing the results of a new study that found that using clot-busting drugs in stroke patients who had recently also been given blood thinners did not raise the risk of bleeding complications.
January 11, 2023
The University of Cincinnati's Alberto Espay, MD, spoke with NBC News about the impact of the cost of newly approved Alzheimer's drug Leqembi.